204 related articles for article (PubMed ID: 34250834)
21. The effect of colchicine on mortality outcome and duration of hospital stay in patients with COVID-19: A meta-analysis of randomized trials.
Kow CS; Lee LH; Ramachandram DS; Hasan SS; Ming LC; Goh HP
Immun Inflamm Dis; 2022 Feb; 10(2):255-264. PubMed ID: 34970856
[TBL] [Abstract][Full Text] [Related]
22. Proactive anti-inflammatory therapy in the advanced stages of a new coronavirus infection. Main results of the inpatient phase of the COLORIT study (Colchicin vs. Ruxolitinib and secukinumab in an open, prospective, randomized trial in patients with novel coronavirus infection COVID-19).
Mareev VY; Orlova YA; Plisuk AG; Pavlikova EP; Akopyan ZA; Matskeplishvili ST; Malahov PS; Krasnova TN; Seredenina EM; Potapenko AV; Agapov МA; Asratyan DA; Dyachuk LI; Samokhodskaya LM; Mershina EM; Sinitsyn VE; Mareev YV; Shatokhina EA; Begrambekova YL; Kamalov AA
Kardiologiia; 2022 Dec; 62(12):11-22. PubMed ID: 36636972
[TBL] [Abstract][Full Text] [Related]
23. Effect of colchicine on the outcomes of patients with COVID-19: a systematic review and meta-analysis of randomised controlled trials.
Lan SH; Hsu CK; Lai CC; Chang SP; Lu LC; Hung SH; Lin WT
Ann Med; 2022 Dec; 54(1):1956-1965. PubMed ID: 35833737
[TBL] [Abstract][Full Text] [Related]
24. Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects.
Al-Kuraishy HM; Al-Gareeb AI; Qusty N; Cruz-Martins N; El-Saber Batiha G
Pulm Pharmacol Ther; 2021 Apr; 67():102008. PubMed ID: 33727066
[TBL] [Abstract][Full Text] [Related]
25. Colchicine: A potential therapeutic tool against COVID-19. Experience of 5 patients.
Montealegre-Gómez G; Garavito E; Gómez-López A; Rojas-Villarraga A; Parra-Medina R
Reumatol Clin (Engl Ed); 2021; 17(7):371-375. PubMed ID: 34301378
[TBL] [Abstract][Full Text] [Related]
26. Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation.
Bonaventura A; Vecchié A; Dagna L; Tangianu F; Abbate A; Dentali F
Inflamm Res; 2022 Mar; 71(3):293-307. PubMed ID: 35113170
[TBL] [Abstract][Full Text] [Related]
27. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
28. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
29. Reducing length of hospital stay with colchicine.
Karakaş Ö; Erden A; Güven SC; Armağan B; Sahiner ES; Kurtipek AC; Inan O; Gemcioglu E; Ateş İ; Omma A; Küçüksahin O
J Infect Dev Ctries; 2022 Jan; 16(1):57-62. PubMed ID: 35192522
[TBL] [Abstract][Full Text] [Related]
30. Ivermectin for preventing and treating COVID-19.
Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
[TBL] [Abstract][Full Text] [Related]
31. Colchicine and mortality in patients with coronavirus disease 2019 (COVID-19) pneumonia: A systematic review, meta-analysis, and meta-regression.
Nawangsih EN; Kusmala YY; Rakhmat II; Handayani DR; Juliastuti H; Wibowo A; Lim MA; Pranata R
Int Immunopharmacol; 2021 Jul; 96():107723. PubMed ID: 34162130
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of colchicine in COVID-19 patients: A systematic review and meta-analysis of randomized control trials.
Yasmin F; Najeeb H; Moeed A; Hassan W; Khatri M; Asghar MS; Naveed AK; Ullah W; Surani S
PLoS One; 2022; 17(4):e0266245. PubMed ID: 35381033
[TBL] [Abstract][Full Text] [Related]
33. Adding Colchicine to the Antiretroviral Medication - Lopinavir/Ritonavir (Kaletra) in Hospitalized Patients with Non-Severe Covid-19 Pneumonia: A Structured Summary of a Study Protocol for a Randomized Controlled Trial.
Dalili N; Kashefizadeh A; Nafar M; Poorrezagholi F; Firouzan A; Samadian F; Samavat S; Ziaie S; Fatemizadeh S
Trials; 2020 Jun; 21(1):489. PubMed ID: 32503620
[TBL] [Abstract][Full Text] [Related]
34. Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis.
Kim MS; An MH; Kim WJ; Hwang TH
PLoS Med; 2020 Dec; 17(12):e1003501. PubMed ID: 33378357
[TBL] [Abstract][Full Text] [Related]
35. Impact of colchicine on mortality and morbidity in COVID-19: a systematic review.
Sanghavi D; Bansal P; Kaur IP; Mughal MS; Keshavamurthy C; Cusick A; Schram J; Yarrarapu SNS; Giri AR; Kaur N; Moreno Franco P; Abril A; Aslam F
Ann Med; 2022 Dec; 54(1):775-789. PubMed ID: 35258357
[TBL] [Abstract][Full Text] [Related]
36. Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review.
Cantini F; Goletti D; Petrone L; Najafi Fard S; Niccoli L; Foti R
Drugs; 2020 Dec; 80(18):1929-1946. PubMed ID: 33068263
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of colchicine in COVID-19: a meta-analysis of randomised controlled trials.
Mehta KG; Patel T; Chavda PD; Patel P
RMD Open; 2021 Oct; 7(3):. PubMed ID: 34810227
[TBL] [Abstract][Full Text] [Related]
38. Effect of increasing doses of colchicine on the treatment of 333 COVID-19 inpatients.
Tiholov R; Lilov AI; Georgieva G; Palaveev KR; Tashkov K; Mitev V
Immun Inflamm Dis; 2024 May; 12(5):e1273. PubMed ID: 38798123
[TBL] [Abstract][Full Text] [Related]
39. A Review of the Rational and Current Evidence on Colchicine for COVID-19.
Ghaith HS; Gabra MD; Nafady MH; Elshawah HE; Negida A; Mushtaq G; Kamal MA
Curr Pharm Des; 2022; 28(39):3194-3201. PubMed ID: 34895117
[TBL] [Abstract][Full Text] [Related]
40. Colchicine use in patients with COVID-19: A systematic review and meta-analysis.
Chiu L; Lo CH; Shen M; Chiu N; Aggarwal R; Lee J; Choi YG; Lam H; Prsic EH; Chow R; Shin HJ
PLoS One; 2021; 16(12):e0261358. PubMed ID: 34962939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
